Patients with McArdle's myopathy lack muscle glycogen phosphorylase (M-GP) activity. Regenerating and cultured muscle of patients with McArdle's myopathy presents a glycogen phosphorylase (GP) activity, but it is not firmly established whether M-GP or non-M-GP isoforms are expressed. We have cultured myoblasts from biopsy specimen of five patients with McArdle's myopathy. Skeletal muscle was cultured aneurally or was innervated by coculture with fetal rat spinal cord explants. In the patients' muscle biopsies and in their cultured innervated and aneural muscle we studied total GP activity, isoenzymatic pattern, reactivity with anti-M-GP antiserum, and presence of M-GP mRNA. There was no detectable enzymatic activity, no immunoreactivity with anti-M-GP antiserum, and no M-GP mRNA in the muscle biopsy of all patients. GP activity, M-GP isozyme, and anti-M-GP antiserum reactivity were present in patients' aneural cultures, increased after innervation, and were undistinguishable from control. M-GP mRNA was demonstrated in both aneural and innervated cultures of patients and control by primer extension and PCR amplification of total RNA. Our studies indicate that the M-GP gene is normally transcribed and translated in cultured muscle of patients with myophosphorylase deficiency.
Introduction
Myophosphorylase deficiency (McArdle's myopathy, glycogenosis type V) is characterized by failure of muscle glycogen breakdown into lactic acid (1) and is due to lack of muscle glycogen phosphorylase (M-GP)' activity (2, 3) . Molecular studies of myophosphorylase deficiency revealed that in most GP, glycogen phosphorylase; IEF, iso-electric focusing; L-GP, livertype phosphorylase; M-GP, muscle glycogen phosphorylase; TTBS, cases the protein is absent and the mRNA is missing or greatly reduced (4) (5) (6) , in some patients there is a normal amount of either full-length or shorter mRNA, and in a few patients an inactive protein of normal or reduced size can be shown by immunoreaction with anti-M-GP antiserum (5) (6) (7) (8) (9) . In human tissues there are three different isoforms ofglycogen phosphorylase (GP) ( 10) , which are encoded by three separate genes (1 1-13). M-GP is expressed mainly in adult skeletal muscle, liver-type phosphorylase (L-GP) is present in liver, brain-type phosphorylase (B-GP) is found mainly in the nervous tissue, L-GP and B-GP are also expressed in most adult tissues other than muscle, and in fetal tissues including skeletal muscle. During muscle maturation, L-GP and B-GP isozymes are gradually replaced by M-GP, which is barely detectable in myotubes but is the only isoform in adult muscle fibers ( 14, 15 ) .
The gradual shift of isoenzymatic pattern during myogenesis can be observed also in cultured human muscle that has been innervated by fetal rat spinal'cord neurons ( 16) . Differentiation of human skeletal muscle in culture is greatly enhanced by innervation ( 17) , and the expression of M-GP progressively increases, whereas the expression of L-GP and B-GP gradually decreases ( 18) .
The prevalence of L-GP and B-GP isoforms in cultured myoblasts may explain why myophosphorylase deficiency was never reproduced in culture. In fact the positivity of regenerating muscle fibers (in vivo and in vitro) to histochemical staining for phosphorylase ( 19) was interpreted as reexpression of fetal isoforms (20, 21) , even though other studies had indicated that indeed M-GP was being expressed in immature muscle of myophosphorylase-deficient patients (22) .
In this study we investigate the GP isoenzymatic pattern in cultured muscle of five patients with myophosphorylase deficiency that lacked GP activity, M-GP protein, and M-GP mRNA. Cultured muscle was innervated in order to enhance the expression of muscle-specific proteins, and we studied the pattern of GP isoforms in aneural cultures and in cultures innervated for up to 60 d. Transcript analysis in cultures was carried out by primer extension and PCR amplification.
Methods
Reagents. Purified rabbit muscle phosphorylase b, Klenov DNA polymerase I, and restriction enzymes were from Boehringer Mannheim Biochemicals (Mannheim, Germany), RNA ladder and M-MLV reverse transcriptase were from GIBCO BRL (Grand Island, NY), ribonuclease inhibitor (RNasin), exanucleotides, and ampholyne PAG-PLATE pH 5. Patients. Diagnosis of myophosphorylase deficiency was established in three unrelated patients and in two siblings (total, three males and two females) by clinical criteria, ischemic exercise test, and histochemical and biochemical analyses (Table I) .
Cultures. Muscle specimens were obtained by open biopsy from five patients with myophosphorylase deficiency and from two controls undergoing orthopedic surgery. Myoblasts growing from the muscle explants were cultured in monolayer in 35-mm petri dishes (Falcon Labware, Oxnard, CA) as previously described (23, 24) . Immediately after myoblast fusion, myotubes were cocultured with 12-14-d-old fetal rat spinal cord explants (with dorsal root ganglia attached), as described elsewhere ( 16, 17) . In every dish the areas displaying the characteristic appearance of innervated muscle fibers ( 16, 17) were harvested after the spinal cord explants had been carefully excised and discarded. Areas consisting of flat disperse myotubes, generally far away from the spinal cord explants and not showing any spontaneous contraction, were also harvested and considered "noninnervated" muscle fibers. This method of dissection has proven to be highly reliable in our previous studies (16, 18) . To some dishes spinal cord explants were not added, and these cultures were harvested as "aneural" muscle fibers. Consequently, cultured muscle samples will be referred to as "innervated," "noninnervated," or "aneural."
Few dishes with innervated and noninnervated cultured muscle from control or patient were fixed by air drying, stained for periodic acid-Schiff-positive material (0.5% periodic acid for 3 min, brief wash in water, 10 min in Schiff's reagent, dehydration in ascending alcohol), and observed by light microscopy.
Biochemical studies
Biopsied muscle. Samples obtained from muscle biopsy were homogenized in 9 vol of phosphorylase buffer (40 mM beta-glycerophosphate, 40 mM NaF, 10 mM EDTA, 20 mM beta-mercaptoethanol, pH 6.8).
Homogenates were centrifuged at 10,000 g for 10 min, and supernatants were used. GP activity and glycogen content were measured as described elsewhere (25) . Separation of GP isoforms by iso-electric focusing, and gel staining for GP activity was performed as previously described ( 16) (30) between nucleotides 514 and 495 (5'-CTGAGACTCAGA-TGGCCTCA-3': low-M-GP), as upper primer we chose the 22mer between nucleotides 280 and 301 of the same sequence (5'-CCATGA-CCGGTTTAAAGTCTTC-3': up-M-GP). Both primers had only limited homology with the corresponding sequences of human L-GP and B-GP and of M-GP from other species (rat, rabbit) (13, 30) . Total RNA (100-500 ng) and the downstream primer (5 pM) were annealed by heating (65°C) for 10 min and snap-freezing, and then incubated at 37°C for 1 h in the RT-buffer provided by GIBCO (Fig. 1 ) . Denaturing gels stained with Coomassie blue showed a distinct band comigrating with purified M-GP in the control but not in the samples from the patients (Fig.  2) . Northern blot analysis with human M-GP cDNA showed a band of 3.4 kb in control muscle, but no signal was detectable in any of the patients, even though the amount of the total RNA loaded on the gel was for the patients twice that ofcontrol (Fig. 3) .
Primer extension and PCR amplification of RNA from control muscle with M-GP primers yielded the expected product (Fig. 4) , but no product was seen after amplification of reverse transcribed RNA from the patients.
Cultured muscle. The pattern of growth and the morphology of patients' cultured muscle did not differ from that of control. There was no vacuolization and no increase of intracellular periodic acid-Schiff-positive material. In accord with previous descriptions ( 17), 5-10 d after innervation, cultures from patients and controls contained areas of elongated and spontaneously contracting muscle fibers. There was no obvious difference by light microscopy in the pattern of innervation and contraction between patients' and control cultures.
40 d after innervation total GP activity in innervated cultured muscle was 64.13±18.8 and 54.03±16.2 nmol/min per mg of protein, in cultures from patients and from controls respectively. GP activity was significantly lower in noninnervated cultured muscle: 13.13±3.6 (patients) and 14.56±2.7 (control) nmol/min per mg of protein (Table II) .
When GP isozymes were separated by IEF and stained for GP activity (Fig. 5) , a distinct strong band at pH 6.3, as well as other bands at pH 6.0-5.6, were present in the innervated cultured muscle of all five patients as in control. The band at pH 6. cle (Fig. 5 , lane AM), and corresponds to M-GP. The other bands at lower pH, which are present in cultured muscle but not in adult muscle, correspond to L-GP and B-GP. The bands at pH 6.0-5.8 were also seen in adult liver (Fig. 5, lane L,) , and virtually disappeared when Na2SO4 0.7 M was omitted from the incubation medium (not shown).
In patients' and control noninnervated and aneural cultured muscle the amount of GP focusing at pH 6.3 was much lower than in innervated muscle. Nevertheless, a faint but distinct band was present in all aneural and noninnervated samples (an example of aneural muscle culture from one patient is given in Fig. 5, lane 1-,) . Densitometric analysis of the gels from cultured muscle innervated for 40 d showed that the band corresponding to M-GP accounted for 31.92±10.8% of total GP in patients' cultures, and 32.45±11.78% oftotal GP in con- 5) . In lane cD the PCR amplification product of M-GP cDNA is shown as reference. The product seen in control muscle is absent in the patients. trol cultures. M-GP in aneural and noninnervated cultures was in the range of 2-16% (Table II) .
In Western blots of innervated cultured muscle from patients and controls, the anti-M-GP antiserum recognized a band co-migrating with purified M-GP (Fig. 6 a) , further confirming the presence of M-GP protein in both patients' and control cultured muscle. A much fainter band was also visible in immunoblots of aneural cultures (Fig. 6 b) . The change in M-GP expression in innervated and noninnervated cultured muscle was analyzed in one patient and one control after 20, 30, 40, and 60 d of innervation (Fig. 7) . There was a steady increase in M-GP (expressed as percent of total GP) in innervated cultured muscle ofboth patient and control. M-GP after 60-d innervation was 57% in the patient and 53% in the control, while in noninnervated muscle M-GP was always below 20%.
Northern blot analysis of total RNA from cultured muscle of patients and control did not show any detectable band.
Primer extension and PCR amplification of total RNA from innervated and aneural muscle yielded in all patients and in controls a single product ofthe same size as the one obtained after PCR amplification of the human M-GP cDNA or after primer extension and PCR amplification of RNA from adult normal muscle (Fig. 8, a and b) . The identity of the amplified sequence was further confirmed by restriction endonuclesase digestion (HaeII), which gave the expected fragments (not shown).
Discussion
The cultured muscle of our five patients with myophosphorylase deficiency expressed active M-GP, similar to the isoform found in control adult skeletal muscle by IEF or immunoblot with anti-M-GP antiserum. Both assays had shown complete absence of the enzyme in the adult muscle of all five patients. , innervated muscle fibers from the five patients with myophosphorylase deficiency; lane 1-, aneural muscle fibers from one patient. GP isozymes were separated by IEF on PAGE, and GP activity was detected after incubation for 24 h at 260C in a medium containing 2% glycogen, 40 mM glucose-l-phosphate, 2 mM AMP, 0.7 M Na2SO4, and staining in a 1:30 dilution of 4% iodine, 6% KI, and 10% acetic acid.
The amount of M-GP found in cultured muscle was minimal compared with adult muscle, but there was no difference between patients' and control cultures. The degree of M-GP increase after innervation was comparable in patients' and control cultures, suggesting that regulation of M-GP expression in this model is not altered in myotubes from patients with myophosphorylase deficiency. to 5-) . Condition of the run, transfer, and immunoreaction were as described in Fig. 1 and in Methods. (33, 34) . PCR amplification of DNA extracted from innervated cultured muscle of Duchenne patients showed the absence of this exon's amplification product (35) .
Other authors have failed to detect M-GP in cultured human muscle from patients and control (20, 21 ), probably because their cultures were analyzed at a very immature stage, and the assays utilized were not very sensitive. Slab gel IEF (as used in this study) offers clear advantages in both definition and separation over the assays used in the previous studies (36 (4, (39) (40) (41) . A forthcoming report seems to indicate in many l * | patients the presence of a point mutation introducing a stop codon in the first exon of the gene (4 la). The characterization of our patients in this respect will be of great interest.
Human M-GP transcription start site has been mapped 76 bp upstream from the translation start site, regulatory elements are present further upstream (38) , and maybe also in the 3' untranslated region (30) . In particular a decamer at position -592 has been identified as the tissue-specific regulatory element for human M-GP (38) . A transcriptional repressor sequence may be present within the 280 bp between -612 and primer-ex--892 (38) . The factors activating and controlling these cis-act- The crucial question is why M-GP is not expressed in patients' adult muscle, but is expressed when the same muscle is induced to proliferate in culture. Possible explanations include: activation during early muscle differentiation of a M-GP pseudogene that is shut off in adult muscle, reversion during satellite cells replication of a point mutation blocking M-GP transcription in adult muscle, or existence for M-GP gene ofdifferent regulatory mechanisms in myotubes and in adult fibers.
A related sequence mapping on chromosome 10 was described for B-GP ( 13) , but no evidence of M-GP related sequences was ever reported, and recent data on chromosome localization indicate hybridization of M-GP probe to a unique site (40) . Reversion ofdeleterious mutation can occur, but it is a very rare casual event. We observed five different patients and over 200 culture dishes, and the results were always comparable. This makes very unlikely a reversion event, unless one postulates an exceptional frequency and a very strong selective advantage of the reverted cells. The last hypothesis is the most appealing and should be tested. There are several possible mechanisms: developmental-stage specific transcription activation (as observed for GP in Dictyostelium, [42] ), message stabilization induced by growth factors or hormones (as seen for muscle-specific creatine kinase and myosin heavy chain mRNAs, [431) , and accumulation during life of factors acting on the repressor sequence.
Sequence analysis of all known regulatory elements of M-GP gene in myophosphorylase deficiency patients, and identification of the DNA-binding proteins acting on them during the various phases of muscle differentiation, will contribute to the understanding ofthe molecular mechanisms leading to the reexpression of the defective enzyme. One might then seek a way to mimic in vivo the regenerative state to induce M-GP expression in an adult muscle fiber population, as a way to clinically benefit the patients.
